<VariationArchive RecordType="classified" VariationID="550821" VariationName="NM_000022.4(ADA):c.396dup (p.Val133fs)" VariationType="Duplication" Accession="VCV000550821" Version="12" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2023-12-30" DateCreated="2018-08-05" MostRecentSubmission="2023-12-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="549388" VariationID="550821">
      <GeneList>
        <Gene Symbol="ADA" FullName="adenosine deaminase" GeneID="100" HGNC_ID="HGNC:186" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q13.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="44619522" stop="44651699" display_start="44619522" display_stop="44651699" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="43248162" stop="43280375" display_start="43248162" display_stop="43280375" Strand="-" />
          </Location>
          <OMIM>608958</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000022.4(ADA):c.396dup (p.Val133fs)</Name>
      <CanonicalSPDI>NC_000020.11:44625650:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>20q13.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="44625650" stop="44625651" display_start="44625650" display_stop="44625651" variantLength="1" positionVCF="44625650" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="43254291" stop="43254292" display_start="43254291" display_stop="43254292" variantLength="1" positionVCF="43254291" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <OtherNameList>
        <Name>NM_000022.4(ADA):c.396dup</Name>
        <Name>p.Val133fs</Name>
      </OtherNameList>
      <ProteinChange>V133fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000022.2" sequenceAccession="NM_000022" sequenceVersion="2" change="c.396dupA">
            <Expression>NM_000022.2:c.396dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.43254292dup" Assembly="GRCh37">
            <Expression>NC_000020.10:g.43254292dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.44625651dup" Assembly="GRCh38">
            <Expression>NC_000020.11:g.44625651dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007385.1" sequenceAccession="NG_007385" sequenceVersion="1" change="g.31085dup">
            <Expression>NG_007385.1:g.31085dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000022.4" sequenceAccession="NM_000022" sequenceVersion="4" change="c.396dup" MANESelect="true">
            <Expression>NM_000022.4:c.396dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000013.2" sequenceAccession="NP_000013" sequenceVersion="2" change="p.Val133fs">
            <Expression>NP_000013.2:p.Val133fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322051.2" sequenceAccession="NM_001322051" sequenceVersion="2" change="c.396dup">
            <Expression>NM_001322051.2:c.396dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308980.1" sequenceAccession="NP_001308980" sequenceVersion="1" change="p.Val133fs">
            <Expression>NP_001308980.1:p.Val133fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_136160.2" sequenceAccession="NR_136160" sequenceVersion="2" change="n.488dup">
            <Expression>NR_136160.2:n.488dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322050.2" sequenceAccession="NM_001322050" sequenceVersion="2" change="c.73+805dup">
            <Expression>NM_001322050.2:c.73+805dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_16" sequenceAccession="LRG_16">
            <Expression>LRG_16:g.31085dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_16t1" sequenceAccession="LRG_16t1">
            <Expression>LRG_16t1:c.396dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000022.3" sequenceAccession="NM_000022" sequenceVersion="3" change="c.396dupA">
            <Expression>NM_000022.3:c.396dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1555844617" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000022.4(ADA):c.396dup (p.Val133fs) AND Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency" Accession="RCV000665672" Version="11">
        <ClassifiedConditionList TraitSetID="495">
          <ClassifiedCondition DB="MedGen" ID="C1863236">Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2023-11-14" SubmissionCount="5">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000022.4(ADA):c.396dup (p.Val133fs) AND Severe combined immunodeficiency disease" Accession="RCV000780819" Version="2">
        <ClassifiedConditionList TraitSetID="8766">
          <ClassifiedCondition DB="MedGen" ID="C0085110">Severe combined immunodeficiency disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-15" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-14" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2018-08-05" MostRecentSubmission="2023-12-30">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21664875</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26255240</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26376800</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/4ab2445c-e8c4-479d-87cb-de2f90731ef3</URL>
        </Citation>
        <DescriptionHistory Dated="2023-11-19">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-04-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="495" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3720" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ADA-SCID</ElementValue>
                <XRef Type="MIM" ID="102700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adenosine deaminase deficient severe combined immunodeficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe combined immunodeficiency due to ADA deficiency</ElementValue>
                <XRef ID="Adenosine+Deaminase+Deficiency/228" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCID DUE TO ADA DEFICIENCY, EARLY-ONSET</ElementValue>
                <XRef Type="MIM" ID="102700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADA deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe combined immunodeficiency due to adenosine deaminase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency</ElementValue>
                <XRef ID="MONDO:0007064" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5748" />
                <XRef ID="5748" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Adenosine deaminase (ADA) deficiency is a systemic purine metabolic disorder that primarily affects lymphocyte development, viability, and function. The clinical phenotypic spectrum includes: Severe combined immunodeficiency disease (SCID), often diagnosed by age six months and usually by age 12 months; Less severe "delayed" onset combined immune deficiency (CID), usually diagnosed between age one and ten years; "Late/adult onset" CID, diagnosed in the second to fourth decades; Benign "partial ADA deficiency" (very low or absent ADA activity in erythrocytes but greater ADA activity in nucleated cells), which is compatible with normal immune function. Infants with typical early-onset ADA-deficient SCID have failure to thrive and opportunistic infections associated with marked depletion of T, B, and NK lymphocytes, and an absence of both humoral and cellular immune function. If immune function is not restored, children with ADA-deficient SCID rarely survive beyond age one to two years. Infections in delayed- and late-onset types (commonly, recurrent otitis, sinusitis, and upper respiratory) may initially be less severe than those in individuals with ADA-deficient SCID; however, by the time of diagnosis these individuals often have chronic pulmonary insufficiency and may have autoimmune phenomena (cytopenias, anti-thyroid antibodies), allergies, and elevated serum concentration of IgE. The longer the disorder goes unrecognized, the more immune function deteriorates and the more likely are chronic sequelae of recurrent infection.</Attribute>
                <XRef ID="NBK1483" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301656</ID>
                <ID Source="BookShelf">NBK1483</ID>
              </Citation>
              <XRef ID="277" DB="Orphanet" />
              <XRef ID="C1863236" DB="MedGen" />
              <XRef ID="MONDO:0007064" DB="MONDO" />
              <XRef Type="MIM" ID="102700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8766" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="6210" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Severe combined immunodeficiency</ElementValue>
                <XRef ID="HP:0004430" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0015974" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe Combined Immune Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe combined immunodeficiency disease</ElementValue>
                <XRef ID="31323000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bubble boy disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SCID</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="mode of inheritance">X-Linked or Autosomal recessive</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7628" />
                <XRef ID="7628" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/SCID.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Severe Combined Immunodeficiency (SCID) and Conditions Associated with T Cell Lymphopenia, 2012</CitationText>
              </Citation>
              <XRef ID="183660" DB="Orphanet" />
              <XRef ID="C0085110" DB="MedGen" />
              <XRef ID="D016511" DB="MeSH" />
              <XRef ID="MONDO:0015974" DB="MONDO" />
              <XRef Type="primary" ID="HP:0004430" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1540135" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="25191|OMIM:102700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000789831" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-02-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21664875</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="20" alternateAllele="CT" referenceAllele="C" start="43254291" stop="43254291" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000022.2:c.396dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="102700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3868329" SubmissionDate="2021-10-12" DateLastUpdated="2021-10-16" DateCreated="2021-10-16">
        <ClinVarSubmissionID localKey="NM_000022.4:c.396dup|OMIM:102700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001977515" DateUpdated="2021-10-16" DateCreated="2021-10-16" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000022.4:c.396dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="102700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10430414</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1795013" SubmissionDate="2022-05-12" DateLastUpdated="2022-05-16" DateCreated="2019-06-02">
        <ClinVarSubmissionID localKey="NM_000022.3:c.396dupA|MedGen:C0085110" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000918393" DateUpdated="2022-05-16" DateCreated="2019-06-02" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21664875</ID>
          </Citation>
          <Comment>Variant summary: ADA c.396dupA (p.Val133SerfsX38) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 184218 control chromosomes. c.396dupA has been reported in the literature in a compound heterozygote individual affected with Severe Combined Immunodeficiency Syndrome (Felgentreff_2011). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000022.3:c.396dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0085110" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11463985</SubmissionName>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2368413" SubmissionDate="2023-01-06" DateLastUpdated="2023-02-07" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4960251|MedGen:C1863236" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001203216" DateUpdated="2023-02-07" DateCreated="2020-04-15" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26255240</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26376800</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21664875</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val133Serfs*38) in the ADA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ADA are known to be pathogenic (PMID: 26255240, 26376800). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with atypical severe combined immunodeficiency deficiency (PMID: 21664875). ClinVar contains an entry for this variant (Variation ID: 550821). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.43254291_43254292insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1863236" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="7682825" SubmissionDate="2023-11-14" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="4ab2445c-e8c4-479d-87cb-de2f90731ef3" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004102818" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen" OrgID="509310" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-14">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/4ab2445c-e8c4-479d-87cb-de2f90731ef3</URL>
          </Citation>
          <Comment>The c.396dup (p.Val133Serfs*38) (NM_000022.4) variant in ADA is a frameshift variant predicted to cause a premature stop codon in biologically relevant exon 5/12 leading to nonsense-mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). At least one patient with this variant displayed Diagnostic criteria for Leaky SCID (0.5pt) + T-B-NK- lymphocyte subset profile (0.5pt) = 1 point TOTAL, which is highly specific for SCID (PP4_Met, PMID: 21664875). In summary, this variant meets the criteria to be classified as pathogenic for SCID. ACMG/AMP criteria applied, as specified by the ClinGen SCID-VCEP: PVS1, PM2_Supporting, and PP4. (VCEP specifications version 1).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen SCID ACMG Specifications ADA V1.0.0</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/fpnk73lm/clingen_scid_acmg_specifications_ada_v1.0.0_1_.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000022.4(ADA):c.396dup</Name>
            <Name>p.Val133fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.11:g.44625651dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0007064" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13972535</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7865903" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000022.4:c.396dup|OMIM:102700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004213367" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000022.4:c.396dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="102700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3868329" TraitType="Disease" MappingType="XRef" MappingValue="102700" MappingRef="OMIM">
        <MedGen CUI="C1863236" Name="Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1540135" TraitType="Disease" MappingType="XRef" MappingValue="102700" MappingRef="OMIM">
        <MedGen CUI="C1863236" Name="Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7865903" TraitType="Disease" MappingType="XRef" MappingValue="102700" MappingRef="OMIM">
        <MedGen CUI="C1863236" Name="Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1795013" TraitType="Disease" MappingType="XRef" MappingValue="C0085110" MappingRef="MedGen">
        <MedGen CUI="C0085110" Name="Severe combined immunodeficiency disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2368413" TraitType="Disease" MappingType="XRef" MappingValue="C1863236" MappingRef="MedGen">
        <MedGen CUI="C1863236" Name="Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7682825" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0007064" MappingRef="MONDO">
        <MedGen CUI="C1863236" Name="Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

